NDLS vs RARE · rev $250.8M vs rev $350.0M
Noodles & Company (NDLS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Noodles & Company (NDLS) is a restaurants company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NDLS revenue for 2026-06-30 was $250.8M. Net income was -$7.4M. NDLS currently screens at market cap $36.8M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
NDLS currently screens at market cap $36.8M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NDLS and RARE stock pages for the full models.
Not investment advice.